# EAA/Therapy for Treating Children With ADHD

> **NCT02482649** · NA · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 46 (estimated)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **BEHAVIORAL:** EAA/T
- **DRUG:** Methylphenidate
- **DRUG:** Atomoxetine

## Key facts

- **NCT ID:** NCT02482649
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2015-08
- **Final completion:** 2015-12
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2015-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02482649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02482649, "EAA/Therapy for Treating Children With ADHD". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT02482649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*